Moleculin Biotech Inc MBRX

NAS: MBRX | ISIN: US60855D1019 30/04/2025

1,060 USD (+3,92%)

(+3,92%) 30/04/2025

Grafiek Moleculin Biotech Inc

Grafiek Moleculin Biotech Inc

1 dag1d 3,92%
1 week1w -4,50%
1 maand1m 10,52%
3 maanden3m -23,75%
6 maanden6m -56,73%
1 jaar1j -79,05%
5 jaar5j -83,49%

Moleculin Biotech Inc in het nieuws

Toon enkel gratis nieuws

11 maart 2025 · Moleculin Biotech, Inc. Participates in the Virtual Investor "Top 5 for '25" On-Demand Conference · Persbericht

10 maart 2025 · Moleculin to Present at the 37th Annual ROTH Conference · Persbericht

6 maart 2025 · Moleculin Announces Additional Annamycin Patent Allowances to Enhance Global Exclusivity · Persbericht

3 maart 2025 · Moleculin Abstract Accepted for Poster Presentation at the Acute Leukemias XIX (ISALXIX) International Symposium · Persbericht

9 september 2024 · Moleculin Announces First Patients Treated in Phase 2 Clinical Trial of STAT3 Inhibitor in Combination with Radiation for the Treatment of Glioblastoma · Persbericht

3 september 2024 · Moleculin to Present at the H.C. Wainwright 26th Annual Global Investment Conference · Persbericht

26 augustus 2024 · Moleculin to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar · Persbericht

19 augustus 2024 · Moleculin Announces Closing of up to $16.5 Million Public Offering · Persbericht

16 augustus 2024 · Moleculin Announces Pricing of up to $16.5 Million Public Offering · Persbericht

14 augustus 2024 · Moleculin Reports Second Quarter 2024 Financial Results and Provides Corporate Update · Persbericht

Profiel Moleculin Biotech Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.moleculin.com

Hoofdzetel: Houston, Texas Verenigde Staten

Werknemers: 20

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe